The term Antibiotic refers to antimicrobial which are obtained or derived from the bacteria or molds. Antibacterial drugs have different modes of action which includes increasing the cell membrane permeability, interfering with protein synthesis, nucleic acid metabolism, inhibiting cell wall synthesis. These drugs are used in the treatment as well as prevention of bacterial infection. These antibiotic drugs inhibit the growth of or kill the bacteria. The term antibiotic is used to refer to any substance used against microbes.
The Antibacterial Drugs market is expected to be around US$ 39.50 Billion by 2028 growing at a CAGR of 1% during the given forecast period.
The major driving factors of Antibacterial Drugs Market are as follows:
• There is a very high prevalence of infectious diseases.
• The research and development activities have increased.
• Product differentiation through various methods.
• Increased government support.
The restraining factors of Antibacterial drugs Market are as follows:
• Rise in drug resistant species.
• Launch of the generic drugs.
• Patent expiry.
The Antibacterial Drugs Market is segmented on the basis of Class as Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones/Fluoroquinolones, Macrolides, Phenicols, Miscellaneous Antibacterials.
The Antibacterial Drugs Market geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global Antibacterial Drugs Market and related technologies.
2) Analyses of global market trends and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Antibacterial Drugs Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for various types of Antibacterial Drugs Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Allergen plc, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly & Co., Forest Laboratories, Inc., GlaxoSmithKline plc, Merck & Co., Inc. Novartis AG, Pfizer, Inc., and Sanofi. are provided in the report. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Market Segmentation of Antibacterial Drugs is as follows:
By Drug Class
• Aminoglycosides
• B-Lactams
• Tetracyclines
• Sulfonamides
• Quinolones/Fluoroquinolones
• Macrolides
• Phenicols
• Miscellaneous Antibacterials
By Geography
• North America
• Asia Pacific
• Europe
• Latin America and Africa
• Middle East
Reasons to buy this Report:
1) Obtain the most up to date information available on all active and planned Antibacterial Drugs Market globally.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Antibacterial Drugs market and unit capacity data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Autologous Stem Cell and Non-Stem Cell Based Therapies Market
chapter 1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Antibacterial Drugs Market
2.2 Comparative Analysis: Global Antibacterial Drugs Market, by Geography, 2016 and 2024 (Value %)
Chapter 3 Market Overview
3.1 Introduction to Antibacterial Drugs
3.2 Drivers
3.2.1 High prevalence of infectious diseases
3.2.2 Government support in research and development of antibacterial drugs
3.3 Restraints
3.3.1 Upcoming patent expirations and subsequent launch of generics
3.3.2 Rise in drug resistant species
3.4 Opportunities
3.4.1 Product differentiation through technological innovation, use of monoclonal antibodies (mAbs), combination products, new formulations and indications
3.5 Market Attractiveness Analysis: Global Antibacterial Drugs Market, by Geography
Chapter 4 Global Antibacterial Drugs Market Revenue, by Class, 2023 – 2028 (USD Million)
4.1 Overview
4.1.1 Global Antibacterial Drugs Market Revenue, by Class, 2023 – 2028 (USD Million)
4.2 Aminoglycosides
4.2.1 Global Aminoglycosides Market Revenue, 2023 – 2028 (USD Million)
4.3 B-Lactams
4.3.1 Global β-Lactams Market Revenue, 2023 – 2028 (USD Million)
4.3.2 Penicillins
4.3.3 Carbapenems
4.3.4 Cephalosporins
4.4 Tetracyclines
4.4.1 Global Tetracyclines Market Revenue, 2023 – 2028 (USD Million)
4.5 Sulfonamides
4.5.1 Global Sulfonamides Market Revenue, 2023 – 2028 (USD Million)
4.6 Quinolones/Fluoroquinolones
4.6.1 Global Quinolones/Fluoroquinolones Market Revenue, 2023 – 2028 (USD Million)
4.7 Macrolides
4.7.1 Global Macrolides Market Revenue, 2023 – 2028 (USD Million)
4.8 Phenicols
4.8.1 Global Phenicols Market Revenue, 2023 – 2028 (USD Million)
4.9 Miscellaneous Anti-bacterial
4.9.1 Global Miscellaneous Antibacterial Market Revenue, 2023 – 2028 (USD Million)
Chapter 5 Global Antibacterial Drug Pipeline Analysis
5.1 Introduction
5.2 Actoxumab/bezlotoxumab (MK-3415A)
5.2.1 Actoxumab/Bezlotoxumab (MK-3415A) Market Revenue, 2023 – 2028 (USD Million)
5.3 Surotomycin (MK-4261)
5.3.1 Surotomycin (MK-4261) Market Revenue, 2023 – 2028 (USD Million)
5.4 Arikace
5.4.1 Arikace Market Revenue, 2023 – 2028 (USD Million)
5.5 Cadazolid
5.5.1 Cadazolid Market Revenue, 2019 – 2025 (USD Million)
5.6 Ciprofloxacin/Fluocinolone Acetonide
5.6.1 Ciprofloxacin/Fluocinolone Acetonide Market Revenue, 2023 – 2028 (USD Million)
5.7 Zempia (E-101)
5.7.1 Zempia (E-101) Market Revenue, 2023 – 2028 (USD Million)
5.8 Carbavance (meropenem/RPX7009)
5.8.1 Carbavance Market Revenue, 2023 – 2028 (USD Million)
5.9 Ozenoxacin
5.9.1 Ozenoxacin Market Revenue, 2023 – 2028 (USD Million)
5.10 RHB-105
5.10.1 RHB-105 Market Revenue, 2019 – 2025 (USD Million)
5.11 SPL7013
5.11.1 SPL7013 Market Revenue, 2023 – 2028 (USD Million)
5.12 SYM-1219
5.12.1 SYM-1219 Market Revenue, 2023 – 2028 (USD Million)
5.13 Delafloxacin
5.13.1 Delafloxacin Market Revenue, 2023 – 2028 (USD Million)
5.14 Solithromycin
5.14.1 Solithromycin Market Revenue, 2023 – 2028 (USD Million)
5.15 Eravacycline
5.15.1 Eravacycline Market Revenue, 2023 – 2028 (USD Million)
5.16 Delamanid
5.16.1 Delamanid Market Revenue, 2023 – 2028 (USD Million)
5.17 Omadacycline (PTK-0796)
5.17.1 Omadacycline Market Revenue, 2023 – 2028 (USD Million)
5.18 Plazomycin
5.18.1 Plazomicin Market Revennue, 2023 – 2028 (USD Million)
Chapter 6 Global Antibacterial Drugs Market Revenue, by Geography, 2023 – 2028 (USD Million)
6.1 Overview
6.1.1 Global Antibacterial Drugs Market Revenue, by Geography, 2023 – 2028 (USD Million)
6.2 North America
6.2.1 North America Antibacterial Drugs Market Revenue, 2023 – 2028 (USD Million)
6.3 Europe
6.3.1 Europe Antibacterial Drugs Market Revenue, 2023 – 2028 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Antibacterial Drugs Market Revenue, 2023 – 2028 (USD Million)
6.5 Latin America
6.5.1 Latin America Antibacterial Drugs Market Revenue, 2023 – 2028 (USD Million)
6.6 Rest of the World
6.6.1 Rest of the World (RoW) Antibacterial Drugs Market Revenue, 2015 – 2025 (USD Million)
Chapter 7 Recommendations
7.1 Development of combination products
7.2 Rising demand for generic antibacterial drugs from developing anddeveloped countries is potential market for new entrants and generic manufacturers
7.3 Strategic collaborations with small biotechnology and research companies
7.4 Focusing on Gram-negative bacteria
Chapter 8 Company Profiles
8.1 AstraZeneca plc
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Allergan plc (Actavis Plc)
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Mergers and Acquisitions
8.2.5 Recent Developments
8.3 Bayer AG
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Bristol-Myers Squibb Company
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.5 Recent Developments
8.5 Eli Lilly and Company
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 GlaxoSmithKline plc
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Johnson & Johnson
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Merck & Co., Inc.
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Novartis AG
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Pfizer, Inc.
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategies
8.10.5 Recent Developments
8.11 Sanofi
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
The Market Segmentation of Antibacterial Drugs is as follows:
By Drug Class
• Aminoglycosides
• B-Lactams
• Tetracyclines
• Sulfonamides
• Quinolones/Fluoroquinolones
• Macrolides
• Phenicols
• Miscellaneous Antibacterials
By Geography
• North America
• Asia Pacific
• Europe
• Latin America and Africa
• Middle East
SUBSCRIBE TO OUR NEWSLETTERS
